Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
2
50%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery

NCT05954767
completedphase_2

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

NCT05769257
completedphase_2

A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

NCT03937505
completedphase_1

IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics

NCT03006237

Clinical Trials (4)

Showing 4 of 4 trials
NCT05954767Phase 3

IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery

Completed
NCT05769257Phase 2

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

Completed
NCT03937505Phase 2

A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

Completed
NCT03006237Phase 1

IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4